MIR155HG and neoplasm: We observed significant changes in tumor growth in immunodeficient mice between MIR155HG overexpression and the control group or MIR155HG knockdown and the control (Figs. 1G, H and S1E), which supported the tumor intrinsic oncogenic role of MIR155HG.